Updated Jul 16, 2026
Dallara Que has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Dallara Que is the Chief Executive Officer of MiniMed Group, Inc., a company involved in the medical technology sector, particularly focusing on diabetes management solutions. As CEO, she is responsible for overseeing the company's strategic direction and operations.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | MMED | MiniMed Group, Inc. | A — Grant or award | 297.6K | $0.00 | |
| 2026-05-06 | LSCC | LATTICE SEMICONDUCTOR CORP | A — Grant or award | 1.8K | $0.00 | |
| 2026-03-27 | MMED | MiniMed Group, Inc. | F — Tax withholding / forfeiture | 4.8K | $16.31 | $78K |
| 2026-03-13 | MMED | MiniMed Group, Inc. | A — Grant or award | 22.9K | — | |
| 2026-03-13 | MMED | MiniMed Group, Inc. | A — Grant or award | 51.0K | — | |
| 2026-03-13 | MMED | MiniMed Group, Inc. | A — Grant or award | 80.8K | — | |
| 2026-03-13 | MMED | MiniMed Group, Inc. | A — Grant or award | 57.2K | — | |
| 2026-03-13 | MMED | MiniMed Group, Inc. | A — Grant or award | 127.6K | — | |
| 2026-03-13 | MMED | MiniMed Group, Inc. | A — Grant or award | 281.9K | — |
Dallara Que is the Chief Executive Officer of MiniMed Group, Inc., a company involved in the medical technology sector, particularly focusing on diabetes management solutions. As CEO, she is responsible for overseeing the company's strategic direction and operations.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dallara Que profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.